FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2620694890> ?p ?o ?g. }

• W2620694890 abstract "Distant metastasis of triple-negative breast cancer (TNBC) to other organs, e.g., the lungs, has been correlated with poor survival rates among breast cancer patients. Therefore, the identification of useful therapeutic targets to prevent metastasis or even inhibit tumor growth of TNBC is urgently needed. Gαh is a novel GTP-binding protein and known as an inactive form of calcium-dependent tissue transglutaminase. However, the functional consequences of transamidating and G-protein activities of tissue transglutaminase in promoting cancer metastasis are still controversial. Kaplan-Meier analyses were performed to estimate the prognostic values of Gαh and PLCδ1 by utilizing public databases and performing immunohistochemical staining experiments. Cell-based invasion assays and in vivo lung colony-forming and orthotropic lung metastasis models were established to evaluate the effectiveness of interrupting the protein-protein interaction (PPI) between Gαh and PLCδ1 in inhibiting the invasive ability and metastatic potential of TNBC cells. Here, we showed that the increased level of cytosolic, not extracellular, Gαh is a poor prognostic marker in breast cancer patients and correlates with the metastatic evolution of TNBC cells. Moreover, clinicopathological analyses revealed that the combined signature of high Gαh/PLCδ1 levels indicates worse prognosis in patients with breast cancer and correlates with lymph node metastasis of ER-negative breast cancer. Blocking the PPI of the Gαh/PLCδ1 complex by synthetically myristoylated PLCδ1 peptide corresponding to the Gαh-binding interface appeared to significantly suppress cellular invasiveness in vitro and inhibit lung metastatic colonies of TNBC cells in vivo. This study establishes Gαh/PLCδ1 as a poor prognostic factor for patients with estrogen receptor-negative breast cancers, including TNBCs, and provides therapeutic value by targeting the PPI of the Gαh/PLCδ1 complex to combat the metastatic progression of TNBCs." @default.
• W2620694890 created "2017-06-09" @default.
• W2620694890 creator A5003495274 @default.
• W2620694890 creator A5014396870 @default.
• W2620694890 creator A5039205607 @default.
• W2620694890 creator A5040836988 @default.
• W2620694890 creator A5046940548 @default.
• W2620694890 creator A5054555262 @default.
• W2620694890 creator A5073751089 @default.
• W2620694890 date "2017-06-02" @default.
• W2620694890 modified "2023-10-16" @default.
• W2620694890 title "The Gαh-PLCδ1 signaling axis drives metastatic progression in triple-negative breast cancer" @default.
• W2620694890 cites W1556575182 @default.
• W2620694890 cites W1748943496 @default.
• W2620694890 cites W1817697566 @default.
• W2620694890 cites W1976066035 @default.
• W2620694890 cites W1976629146 @default.
• W2620694890 cites W1985459298 @default.
• W2620694890 cites W1987337616 @default.
• W2620694890 cites W1987564363 @default.
• W2620694890 cites W1987662300 @default.
• W2620694890 cites W1995228256 @default.
• W2620694890 cites W2005010556 @default.
• W2620694890 cites W2011915496 @default.
• W2620694890 cites W2012598982 @default.
• W2620694890 cites W2014683547 @default.
• W2620694890 cites W2048000549 @default.
• W2620694890 cites W2060913542 @default.
• W2620694890 cites W2066463226 @default.
• W2620694890 cites W2067715371 @default.
• W2620694890 cites W2068374462 @default.
• W2620694890 cites W2068769869 @default.
• W2620694890 cites W2072167545 @default.
• W2620694890 cites W2079729315 @default.
• W2620694890 cites W2087953477 @default.
• W2620694890 cites W2090142919 @default.
• W2620694890 cites W2095512379 @default.
• W2620694890 cites W2097831215 @default.
• W2620694890 cites W2100545793 @default.
• W2620694890 cites W2111520856 @default.
• W2620694890 cites W2118915702 @default.
• W2620694890 cites W2130881126 @default.
• W2620694890 cites W2136165616 @default.
• W2620694890 cites W2138642705 @default.
• W2620694890 cites W2143202717 @default.
• W2620694890 cites W2149994426 @default.
• W2620694890 cites W2155756657 @default.
• W2620694890 cites W2167641774 @default.
• W2620694890 cites W2168215039 @default.
• W2620694890 cites W2193938114 @default.
• W2620694890 cites W2480024921 @default.
• W2620694890 cites W2547723553 @default.
• W2620694890 cites W4300803924 @default.
• W2620694890 doi "https://doi.org/10.1186/s13045-017-0481-4" @default.
• W2620694890 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5457652" @default.
• W2620694890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28576130" @default.
• W2620694890 hasPublicationYear "2017" @default.
• W2620694890 type Work @default.
• W2620694890 sameAs 2620694890 @default.
• W2620694890 citedByCount "11" @default.
• W2620694890 countsByYear W26206948902019 @default.
• W2620694890 countsByYear W26206948902020 @default.
• W2620694890 countsByYear W26206948902021 @default.
• W2620694890 countsByYear W26206948902022 @default.
• W2620694890 countsByYear W26206948902023 @default.
• W2620694890 crossrefType "journal-article" @default.
• W2620694890 hasAuthorship W2620694890A5003495274 @default.
• W2620694890 hasAuthorship W2620694890A5014396870 @default.
• W2620694890 hasAuthorship W2620694890A5039205607 @default.
• W2620694890 hasAuthorship W2620694890A5040836988 @default.
• W2620694890 hasAuthorship W2620694890A5046940548 @default.
• W2620694890 hasAuthorship W2620694890A5054555262 @default.
• W2620694890 hasAuthorship W2620694890A5073751089 @default.
• W2620694890 hasBestOaLocation W26206948901 @default.
• W2620694890 hasConcept C121608353 @default.
• W2620694890 hasConcept C126322002 @default.
• W2620694890 hasConcept C142724271 @default.
• W2620694890 hasConcept C143998085 @default.
• W2620694890 hasConcept C204232928 @default.
• W2620694890 hasConcept C2776256026 @default.
• W2620694890 hasConcept C2779013556 @default.
• W2620694890 hasConcept C2780110267 @default.
• W2620694890 hasConcept C502942594 @default.
• W2620694890 hasConcept C530470458 @default.
• W2620694890 hasConcept C71924100 @default.
• W2620694890 hasConceptScore W2620694890C121608353 @default.
• W2620694890 hasConceptScore W2620694890C126322002 @default.
• W2620694890 hasConceptScore W2620694890C142724271 @default.
• W2620694890 hasConceptScore W2620694890C143998085 @default.
• W2620694890 hasConceptScore W2620694890C204232928 @default.
• W2620694890 hasConceptScore W2620694890C2776256026 @default.
• W2620694890 hasConceptScore W2620694890C2779013556 @default.
• W2620694890 hasConceptScore W2620694890C2780110267 @default.
• W2620694890 hasConceptScore W2620694890C502942594 @default.
• W2620694890 hasConceptScore W2620694890C530470458 @default.
• W2620694890 hasConceptScore W2620694890C71924100 @default.
• W2620694890 hasFunder F4320322795 @default.
• W2620694890 hasFunder F4320322814 @default.
• W2620694890 hasIssue "1" @default.
• W2620694890 hasLocation W26206948901 @default.

• next